PROSTATE CANCER

This small, early-stage study tested the safety of combining two procedures for men with prostate cancer and an enlarged prostate (BPH). First, doctors implanted a small device (UroLift) to relieve urinary symptoms from the enlarged prostate. Then, patients received a targeted, h…

This study tested a new website designed to help men with low-risk prostate cancer better follow their 'active surveillance' monitoring plan. The goal was to see if the tool was easy to use and helpful for patients and their doctors. Researchers measured whether patients found th…

This study tested a new treatment approach for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. Fifteen participants took high-dose oral testosterone pills for one week, then took a week off, repeating this cycle. If their canc…

This large, completed Phase 3 trial tested whether adding the drug enzalutamide to standard hormone therapy could help men with a high-risk form of prostate cancer. The cancer had stopped responding to standard treatment but had not yet spread. The main goal was to see if the dru…

This study tested whether adding an immunotherapy drug (nivolumab) to one of three other cancer drugs could help men with advanced prostate cancer that had spread and stopped responding to standard hormone therapy. It involved 292 participants and aimed to see if these combinatio…

This early-stage study aimed to check the safety and see how the body processes a specific Angelica herbal supplement in men with prostate cancer. It involved 12 participants to gather initial data on how the supplement behaves in the body and its short-term safety. The goal is t…

This large study aimed to find the best treatment for men with intermediate-risk prostate cancer. It compared standard high-dose radiation therapy alone against radiation combined with short-term hormone-blocking therapy. The goal was to see which approach helped patients live lo…

This study tested the safety and activity of an experimental drug called ARN-509 in men with advanced prostate cancer that had stopped responding to standard hormone therapy. The goal was to find a safe dose and see if the drug could reduce cancer markers and slow disease progres…

This study tested a shorter, more targeted radiation schedule for men whose prostate cancer returned after surgery. Researchers aimed to see if delivering radiation over 2-4 weeks, instead of the usual 6-7, was safe and caused manageable side effects. They also tested if they cou…

This study tested a new oral drug, BXCL701, given alongside the immunotherapy pembrolizumab in men with advanced prostate cancer that had stopped responding to standard treatments. The goal was to find a safe and effective dose and to see if the drug combination could help contro…

This study tested whether the immunotherapy drug nivolumab could control prostate cancer recurrence without using hormone-blocking therapy. It involved 8 men whose prostate cancer had returned after initial treatment and who had specific genetic markers in their tumors. Researche…

This large, completed study compared two different drug combinations for men newly diagnosed with prostate cancer that had spread to other parts of the body. Over 1,300 participants received standard hormone therapy plus either an experimental drug (TAK-700) or an established dru…

This study tested whether a special gel could protect the rectum during radiation treatment for prostate cancer. Researchers implanted the gel between the prostate and rectum in 20 men before radiation therapy. They measured how much the gel reduced radiation exposure to the rect…

This early-stage trial tested the safety and dosing of a new two-drug combination for men with advanced prostate cancer that has spread and is no longer responding to standard hormone-blocking treatments. The study combined an existing prostate cancer drug (enzalutamide) with an …

This early-stage study tested whether injecting a patient's own bone marrow stem cells into the penis could help restore natural erections after prostate cancer surgery. The research involved 18 men who had developed erectile dysfunction following prostate removal. The main goals…

This study tested a combination of two drugs, talazoparib and temozolomide, for men with advanced prostate cancer that had spread and stopped responding to standard hormone therapies. The first part of the study aimed to find the safest dose, and the second part tested how well t…

This study tested whether adding a specialized geriatric care team to standard cancer treatment could help older patients. It involved 792 patients aged 70 and older with various advanced cancers. The goal was to see if this coordinated care approach improved survival and quality…

This early study tested whether adding a single dose of the drug flutamide to standard prostate cancer treatment (hormone therapy plus radiation seeds) causes DNA damage in cancer cells. Researchers enrolled 25 men with prostate cancer who were already scheduled to receive standa…

This study tested a combination of two oral drugs, apalutamide and abiraterone acetate, plus prednisone in men with advanced prostate cancer that had stopped responding to standard hormone therapy. It specifically enrolled 50 African American and 50 Caucasian men to see how well …

This study tested a new approach for men whose prostate cancer returned after initial radiation treatment. It combined a standard internal radiation procedure (brachytherapy) with an experimental targeted radiation drug (177Lu-PSMA). The goal was to see if this combination could …

This study tested a new, highly focused type of radiation for men whose prostate cancer returned after previous radiation treatment. The goal was to find the safest, most effective dose of this 5-session treatment, called stereotactic body radiation therapy (SBRT). Researchers al…

This study aimed to find out if it's better to give radiation treatment right away or to wait and use more sensitive scans later for men whose prostate cancer shows early signs of returning after surgery. It compared two standard approaches: immediate radiation versus monitoring …

This study tested a new type of targeted radiation treatment for men whose prostate cancer has spread to just a few places in the body but still responds to hormone therapy. It aimed to see if this treatment, which delivers radiation directly to cancer cells, could better control…

This study tested whether using two immunotherapy drugs together (nivolumab and ipilimumab) could help men with advanced prostate cancer that had spread and was no longer responding to standard hormone therapy. It compared this combination against using one of the drugs alone or …

This study aimed to find the best radiation treatment for men with intermediate-risk prostate cancer. It compared a two-part treatment (external beam radiation plus internal seed implants) against using the seed implants alone. The goal was to see which approach better controlled…

This study tested if adding targeted radiation to standard drug therapy helps men with advanced prostate cancer that has spread to a few spots. It compared the combination to drug therapy alone. The goal was to see if the radiation could better control the cancer and delay its pr…

This study tested whether combining two, three, or four different immunotherapy drugs could help control advanced prostate cancer that had stopped responding to standard hormone therapy. The trial enrolled 59 adults with this type of cancer or other advanced solid tumors. Researc…

This small pilot study tested a new, targeted laser treatment for men with low-to-intermediate risk prostate cancer. Using real-time MRI guidance, doctors aimed to precisely heat and destroy only the cancerous tumor area, sparing the rest of the prostate. The main goals were to s…

This early-stage study tested a new approach for men with advanced prostate cancer that has stopped responding to standard hormone-blocking therapy. Researchers wanted to see if it was practical and safe to give testosterone through a skin patch, alternating with a cancer drug ca…

This study tested whether adding newer, stronger hormone-blocking drugs to standard therapy could better control prostate cancer that has returned after initial surgery. It involved 504 men whose cancer was detected early through rising PSA levels but had not yet spread. The goal…

This study tested if a special gel, already used to protect the rectum during prostate radiation, could also be used to position patients for treatment. If it works, it could eliminate the need for a separate, invasive procedure to implant metal markers. The research involved 17 …

This study tested whether a special pelvic floor training device called the Pelvic Clock helps men recover faster after robotic prostate cancer surgery. Researchers compared the device plus standard exercises against standard exercises alone in 60 men. The main goal was to see if…

This study tested if adding a new hormone-blocking drug (TAK-700) to standard hormone therapy and radiation could better control high-risk prostate cancer. It involved 239 men and compared the new combination against the standard treatment. The main goals were to see if the stron…

This study tested whether adding two drugs, abiraterone acetate and prednisone, to standard hormone therapy could better control advanced prostate cancer that had not yet spread to other body parts. It involved 131 men whose cancer was resistant to standard hormone treatment but …

This study tested a type of internal radiation treatment called high-dose-rate brachytherapy for several cancers, including cervical, prostate, and breast cancer. Researchers placed temporary radiation sources directly into or near tumors to deliver a strong, focused dose. The ma…

This study looked at whether implantable spacers can safely protect the rectum during radiation treatment for prostate cancer. Researchers examined medical records from 175 men who had already received this treatment. They measured how much the spacer reduced radiation exposure t…

This study tested whether adding a bone-targeting radioactive drug (Radium-223) to precise, high-dose radiation (SABR) works better than radiation alone for men whose prostate cancer has spread to a few spots, including at least one in bone. The goal was to see if this combined a…

This study tested a new type of self-anchoring surgical thread (Symmcora®) used to reconnect the bladder after robot-assisted prostate removal for cancer. The main goal was to see if using this thread made the reconnection step faster than standard methods, while keeping complica…

This study tested a shorter, more intense radiation schedule for men with early-stage prostate cancer. The goal was to see if giving fewer, larger daily doses was as effective as standard treatment while carefully tracking side effects and quality of life. It involved 91 men with…

This small pilot study tested a procedure called prostatic arterial embolization (PAE) in men with early, low-risk prostate cancer who were on active surveillance. The goal was to see if blocking the blood supply to the cancerous part of the prostate could control the tumor local…

This study tested if an aggressive combination of high-dose, targeted radiation and hormone therapy could control prostate cancer that had spread to only a few nearby lymph nodes. It involved 74 men whose cancer returned after initial treatment but was still limited. The goal was…

This study tested whether a combination of three hormone-blocking drugs, given before, during, and after a short, high-dose course of targeted radiation, could effectively prevent prostate cancer from coming back in men with very high-risk disease. It involved 64 men whose cancer…

This study tested whether doubling the dose of the prostate cancer drug abiraterone acetate could help control the disease in patients whose cancer was progressing despite standard treatment. Researchers enrolled 94 men with advanced prostate cancer that had spread and stopped re…

This study tested a shorter radiation treatment for men with early-stage prostate cancer. Instead of the usual 8+ weeks of treatment, participants received just 5 proton radiation sessions over two weeks. Researchers tracked side effects and quality of life for five years to see …

This early-stage study tested a new cancer vaccine designed to teach the body's immune system to recognize and attack tumors. It involved 43 people with advanced colorectal, lung, breast, or prostate cancer that had stopped responding to standard treatments. The main goals were t…

This study tested the drug cabozantinib in men with advanced prostate cancer that had spread and was no longer responding to standard hormone-blocking treatments. The goal was to see if the drug could slow the cancer's growth, especially in patients whose tumors had specific gene…

This study followed 57 men with prostate cancer to check the long-term safety of a medication called degarelix. It was an extension of a previous trial, and patients received treatment for at least five years. The main goal was to monitor for any concerning changes in health, lik…

This study tested a focused ultrasound treatment (HIFU) for men with intermediate-risk prostate cancer that is confined to one area. The goal was to see if precisely destroying only the cancerous part of the prostate could effectively control the disease while causing fewer side …

This study tested whether following a mostly whole food plant-based diet for six months could help men whose prostate cancer is showing signs of activity (rising PSA levels). Eleven men attended cooking and nutrition classes, ate more plant foods, and provided blood samples. Rese…

This study tested a special fluorescent dye called IS-002 to see if it helps surgeons better identify prostate cancer tissue during robotic surgery. The dye is designed to make cancer cells glow under special imaging, potentially allowing for more complete tumor removal. The main…

This study tested a new type of imaging scan to see if it could more accurately find prostate cancer that has spread to other parts of the body, especially bones. Researchers compared this experimental scan to standard scans and optional biopsies in 77 men with advanced prostate …

This study tested a new artificial intelligence (AI) tool designed to help doctors better diagnose prostate cancer. The tool combines information from a blood test and an MRI scan to more accurately tell if a man needs a biopsy. The goal is to reduce the number of unnecessary, in…

This study tested whether new AI-enhanced MRI scans can improve the detection and diagnosis of prostate cancer compared to standard MRI scans. Researchers enrolled 34 men who were scheduled for a prostate MRI to compare the two scanning methods. The goal was to see if the AI scan…

This study tested whether a new, high-resolution ultrasound technology is as good as or better than the standard MRI method for guiding prostate biopsies. It involved 804 men who needed a biopsy due to elevated PSA levels or an abnormal exam. Researchers compared how well each im…

This study tested a new type of PET/CT scan to see how well it can find prostate cancer that has come back after initial surgery or radiation. About 235 men whose PSA levels had risen after treatment received an injection of a radioactive tracer and then had a scan. The main goal…

This study compared two approaches for prostate biopsies to see which better detects cancer. Researchers tested whether 3 targeted biopsies guided by MRI imaging could be as effective as the standard 12 systematic ultrasound-guided biopsies. The study involved 108 men with elevat…

This study compared two different methods for taking prostate tissue samples to check for cancer. Researchers randomly assigned 840 men needing a biopsy to either the standard method (through the rectum) or an alternative method (through the skin). The goal was to see which appro…

This study is testing a new imaging agent called 68Ga-NTA-476 for PET scans in men with prostate cancer. It's the first time this agent is being used in people. The main goals are to see where the agent travels in the body after injection, how it compares to the current standard …

This completed Phase 1 study tested the safety and radiation exposure of a new imaging agent called 68Ga-OncoACP3 for prostate cancer. Twenty men with prostate cancer received a single injection followed by PET/CT scans to see where the tracer goes in the body and measure radiati…

This study compared two methods for detecting aggressive prostate cancer. Researchers tested whether using MRI scans to guide biopsy needles (targeted biopsies) finds dangerous cancers better than the standard method of taking many random samples (systematic biopsies). The trial …

This study compared two different methods of performing prostate biopsies guided by MRI imaging. Researchers wanted to see if a new approach through the perineum (skin between scrotum and anus) causes fewer complications and hospital readmissions than the standard approach throug…

This study aimed to find new markers in blood and urine that could help doctors better detect, predict the course of, and monitor prostate cancer. It involved 80 men, including those with prostate cancer, those suspected of having it, and healthy volunteers. Researchers collected…

This study tested a new type of PET scan designed to find and pinpoint prostate cancer tumors more accurately. It involved 195 men with newly diagnosed, high-risk prostate cancer who were scheduled for surgery. Researchers compared the scan results directly to tissue samples from…

This study tested a new, faster way to check PSA levels, a marker for prostate health. Researchers compared a simple test strip that uses a few drops of blood to the standard, more complex lab test. They wanted to see if the quick test was as accurate for monitoring patients with…

This study directly compared two similar imaging scans (PET scans) in the same patients to see if one was better at finding returning prostate cancer. It involved 55 men whose prostate cancer had returned after surgery, but their PSA blood levels were still very low. The main goa…

This study tested a new method to detect prostate cancer cells in blood samples without needing invasive biopsies. Researchers worked with 127 men who were scheduled for prostate biopsies to see if the blood test could identify cancer cells before the biopsy procedure. The goal w…

This study tested a new type of PET scan designed to find prostate cancer that has returned after initial treatment. It involved 391 men whose blood tests showed rising PSA levels, suggesting the cancer might be back. The main goal was to see how accurately and safely this new sc…

This study tested whether a simple blood test could predict which breast and prostate cancer patients would develop severe long-term side effects from radiation therapy. Researchers measured how certain immune cells reacted to radiation in the lab. The goal was to identify the 5%…

This study tested whether adding a new 2D 'antiscatter grid' to a specialized CT scanner could produce clearer images for cancer patients. It involved 43 adults receiving radiation therapy for prostate, head/neck, or abdominal cancers. Each participant received both a standard sc…

This study tested whether a special fluorescent dye called Cytalux could help surgeons better see prostate cancer tissue during surgery. The dye, injected before the operation, is designed to make cancer cells glow under a special near-infrared light. The goal was to see if this …

This early-stage study tested a new imaging agent called rhPSMA-7.3 (18F) injection. The main goals were to check its safety, see how it moves through the body, and understand how well it can create pictures of prostate cancer. The study involved a small group of healthy voluntee…

This study tested a new type of PET scan, using a tracer called [18F]CTT1057, to see how well it could find and locate returning prostate cancer in men whose PSA levels were rising after initial surgery or radiation. About 190 men participated, each receiving the new scan and a s…

This study tested whether an artificial intelligence (AI) system could help doctors diagnose prostate cancer more accurately from MRI scans. It involved 365 men who were already scheduled for a prostate biopsy. Researchers compared how well the AI system and experienced radiologi…

This study tested whether combining three types of medical scans (PET, CT, and MRI) into one session could help doctors more accurately plan radiation treatment for men with high-risk prostate cancer. The goal was to see if this combined approach better defines the tumor's exact …

This study tested whether patients with breast or prostate cancer could safely take a lower dose of the steroid dexamethasone before receiving the chemotherapy drug docetaxel. The goal was to see if reducing the steroid dose could lessen steroid side effects like mood changes and…

This study tested whether a new support program is practical and helpful for older adults who have finished cancer treatment. A community health worker met with 30 participants to assess their overall health and provide personalized coaching. The goal was to see if this approach …

This study tested whether testosterone replacement therapy could safely improve quality of life for men who had prostate cancer surgery. Researchers enrolled 136 prostate cancer survivors experiencing symptoms like low energy, sexual problems, and physical decline. Participants r…

This small pilot study tested a supportive care program combining wearable fitness trackers with coaching to help Black and Hispanic men with prostate cancer increase exercise and manage treatment side effects. The program aimed to improve quality of life for patients undergoing …

This study tested whether watching 360° virtual reality movies could help reduce fear and anxiety in cancer patients about to begin radiation therapy. Researchers enrolled 292 adults with breast, lung, prostate, head and neck cancers, or brain tumors. Patients watched VR movies s…

This study tested whether a TENS device, which uses mild electrical pulses on the skin, could reduce pain for men undergoing a prostate biopsy. Researchers compared real TENS, a fake (placebo) TENS device, and standard local anesthesia alone in 84 participants. The goal was to se…

This study tested whether acupuncture could help men feel less pain and anxiety during a prostate biopsy. 72 men scheduled for the procedure were randomly given either real acupuncture or a fake 'sham' treatment before their biopsy, along with standard numbing medicine. Researche…

This study created and tested a new education program for men with advanced prostate cancer who are on specific hormone therapies. The goal was to see if teaching patients more about their disease and treatment could help them take their medications correctly and feel better over…

This study tested whether showing patients a video about a prostate biopsy procedure could reduce their pain and anxiety during the test. Researchers compared three groups: one that got standard verbal instructions, one that saw a video, and one that saw still pictures. They foun…

This study tested whether a home-based exercise program is practical and acceptable for men with prostate cancer who are undergoing hormone therapy. It focused on men from underserved groups, including older adults, Black men, and those living in rural areas. The goal was to see …

This small pilot study explored whether acupuncture could help reduce bothersome hot flashes and night sweats in men with prostate cancer who are on hormone therapy. It involved 12 patients and aimed to see if the treatment was acceptable and effective at easing these specific sy…

This study tested whether using a buffered (less acidic) form of the numbing medicine lidocaine reduces the pain and burning sensation patients often feel when it is injected before a prostate biopsy. 350 men scheduled for a prostate biopsy were randomly assigned to receive eithe…

This small, completed pilot study tested a new 12-week occupational therapy program called ActiveHeal EST. It aimed to help breast and prostate cancer survivors build resilience, improve their quality of life, and manage symptoms like pain and fatigue. The program included group …

This study tested an online program called True North Peer Navigation, which connects men who have finished prostate cancer treatment with trained volunteer survivors. The goal was to see if having a peer navigator helps men feel more in control of their health, improves their qu…

This study tested how an antibiotic called rifampicin affects the way the body processes an experimental prostate cancer drug called HRS-5041. Researchers gave both drugs to 16 healthy male volunteers to measure drug levels in their blood. The goal was to understand potential dru…

This study tested an automated system to grow metastatic cancer cells from patients inside fertilized chicken eggs. The goal was to see if this method could reliably produce small tumors (xenografts) from patient samples, which could then be used for future drug testing and resea…

This study aimed to understand how cancer-related DNA in the blood changes before, during, and after surgery. Researchers measured specific DNA fragments in 30 patients undergoing surgery for breast, prostate, or colon cancer. The goal was to gather baseline information to help f…

This study aimed to understand how well patients with advanced breast or prostate cancer follow their prescribed oral medication plans. Researchers observed 200 patients to see what factors, like health status, side effects, or personal support, might make it harder for them to t…

This small, early-stage study tested whether giving the drug rituximab before prostate removal surgery could reduce the number of specific immune cells (B-cells) inside prostate tumors. Eight men with high-risk prostate cancer received four weekly doses of rituximab before their …

This study aims to understand why some prostate cancer lesions appear on MRI scans but not on PSMA-PET scans, and vice versa. Researchers will analyze tissue samples from 30 patients to determine if these 'discordant' lesions represent less aggressive cancer, more dangerous forms…

This study looked at whether PSA blood tests for prostate cancer screening help men aged 75-79 live longer. Researchers analyzed health records from over 250,000 Swedish men to compare those who had screening with those who didn't. The goal was to see if current screening guideli…

This study aimed to see if detailed features from a special type of PET scan (PSMA PET/CT) could help doctors better understand how aggressive a man's prostate cancer is before surgery. Researchers enrolled 70 men with intermediate or high-risk prostate cancer who were scheduled …

This study tested whether providing education about surgical castration (orchiectomy) would make more prostate cancer patients choose this option. It involved 101 men with advanced prostate cancer who were already receiving lifelong hormone-blocking injections. Researchers measur…

This study tested a new set of clear guidelines and patient support services to help primary care doctors make better decisions about prostate cancer screening using the PSA blood test. It involved training doctors and tracking their confidence and actions over a year, while also…

This study observed how Chinese patients with ovarian or prostate cancer tolerated the cancer drug olaparib during regular medical care. Researchers followed 1,018 patients for 6-12 months to track side effects and treatment patterns. The goal was to understand the drug's safety …

This study aimed to understand how common and severe muscle loss (sarcopenia) is in men aged 70 and older who are being treated for prostate cancer. Researchers observed 112 patients who were receiving radiation along with hormone-blocking therapy. The goal was to learn more abou…

This study aimed to understand how different gene activity patterns in prostate tissue relate to cancer development and progression. Researchers analyzed tissue samples from 867 men who were undergoing biopsy or surgery for prostate conditions. The goal was to identify genetic si…

This study looked at whether a genetic test, called a polygenic risk score, can predict if early-stage prostate cancer will get worse in men who are being monitored instead of immediately treated. Researchers analyzed DNA from 185 men with low-risk prostate cancer who were on act…

This small study tested whether special MRI scans taken during radiation treatment for high-risk prostate cancer could help doctors see how the tumor is responding. Researchers wanted to learn if these scans could one day allow doctors to adjust radiation doses during treatment t…

This small, completed pilot study aimed to find a better way to predict how prostate cancer will respond to a standard drug. Researchers tested whether analyzing cancer cells found in the blood (instead of using painful biopsies) could show if the drug was working. Forty men with…

This study looked back at real-world medical records to understand how long men with advanced prostate cancer that still responds to hormone therapy actually stay on two common medications: apalutamide and enzalutamide. Researchers analyzed data from about 1,300 men who were trea…

This study collected MRI and ultrasound images from two prostate cancer patients to create a database. The goal is to help researchers develop future computer systems that can better detect prostate cancer without invasive biopsies. This was a data-gathering step, not a treatment…

This study followed men with BRCA gene mutations (which increase prostate cancer risk) and men without these mutations. Researchers called participants to ask if they had been diagnosed with prostate cancer and to update their family health history. The goal was to gather informa…

This Yale University study aimed to improve how doctors predict the progression of prostate cancer. Researchers analyzed individual cells from standard prostate biopsies taken from 600 men to look for detailed biological patterns. The goal was to find better ways to tell which ca…

This study tested whether smartphones and smartwatches could be used to reliably measure symptoms like fatigue and changes in activity in cancer patients. Researchers enrolled 49 adults with various cancers who were already receiving treatment. They used iPhones and Apple Watches…

This study tested if a one-on-one educational session could help men with prostate cancer decide to get genetic testing. Fifty men who were already recommended for testing took part. Researchers measured if the session increased their knowledge and willingness to proceed with the…

This study looked back at the medical records of 507 veterans with prostate cancer who started taking the oral medication relugolix. The goal was to understand the types of patients who use this newer drug, their health characteristics, and their previous treatments. It did not t…

This study tested two new methods to encourage people at higher risk for hereditary cancers to get recommended genetic testing. Over 800 participants in Michigan were randomly assigned to either use a special website, receive two coaching phone calls, or get standard information.…

This study aimed to create a first-of-its-kind collection of health information and biological samples from African American men in Florida diagnosed with prostate cancer. Researchers enrolled 592 participants to build this resource, which will help scientists study the disease i…

This study tested a digital tool designed to help cancer survivors learn about and decide whether to get genetic testing for hereditary cancer risk. Researchers wanted to see if this smart technology was easy to use and if it encouraged more people to get tested. They compared th…

This study asked patients with prostate cancer and their doctors how they feel about using artificial intelligence (AI) to help diagnose the disease. Researchers surveyed 51 patients across three countries to understand if they would accept AI as a support tool and if they were w…

This study looked back at health records to understand how a newer prostate cancer drug, 177Lu-PSMA-617, was used in real-world practice. Researchers analyzed data from 6,448 patients to see who received the drug, how long they lived, and how their cancer markers changed. The goa…

This study collected blood and urine samples from men with prostate cancer and healthy volunteers. Researchers analyzed the samples to look for genetic differences between cancer cells and normal cells. The goal was to develop a better, non-invasive test to detect prostate cancer…

This study looked back at medical records and PET scans from 168 men with advanced prostate cancer who received standard first-line treatment. Researchers created a prediction model that combines scan results with patient information to estimate how quickly and effectively treatm…

This study explored how men without prostate cancer think about their genetic risk for the disease. Researchers asked 100 racially diverse men, particularly focusing on men of African ancestry, about their risk perceptions and willingness to provide saliva samples. The saliva was…

This study aimed to find biological markers that could predict whether a patient's advanced prostate cancer would respond to specific treatments. Researchers analyzed tiny molecules called microRNAs in blood and tissue samples from 33 patients. The goal was to help doctors choose…

This study aimed to understand whether hormone therapy for prostate cancer affects heart function. Researchers compared heart measurements in three small groups: patients who received the therapy, patients who didn't, and cancer-free individuals. The goal was to gather informatio…

This study observed how hormone therapy affects quality of life in older men with prostate cancer. Researchers followed 831 men aged 60 and older for six months after they started standard hormone treatment. The goal was to understand how different age groups experience side effe…

This study surveyed 109 breast and prostate cancer patients to understand how often they used vitamins, supplements, and other alternative therapies while undergoing radiation treatment. Researchers asked patients at three different times to see if their use of these therapies ch…

This study aimed to test if a newer, more sensitive type of medical camera could accurately measure prostate cancer using a radioactive tracer called Lutetium-177. Researchers first tested the camera's settings on a model (a phantom), then applied those settings to review past sc…

This study observed how a targeted radiation drug was used to treat men with advanced prostate cancer in real-world medical settings. It followed 1,247 patients to understand their characteristics, how they were treated, and their outcomes. The goal was to gather knowledge about …

This study tested an educational program designed to improve how African American men and their doctors talk about and decide on prostate cancer screening. 161 men aged 40-69 were randomly assigned to either receive the educational materials or standard care. The goal was to see …

This study aimed to understand why a common prostate cancer treatment (androgen deprivation therapy or ADT) increases the risk of high blood pressure and heart disease. Researchers measured how the nervous system and kidneys control blood pressure in a small group of men before a…

This study tested whether patient navigators could help Black breast and prostate cancer patients complete their radiation therapy. Researchers worked with 30 Black patients to understand what barriers prevent treatment completion and whether navigator support makes a difference.…

This study aimed to create a tool to better predict prostate cancer severity. It involved 382 men diagnosed with low-grade cancer who were scheduled for prostate removal surgery. Researchers collected their tissue samples, blood, and health information to find clues that could re…

This study tested a training program called KanSurvive-ECHO to help rural primary care doctors provide better follow-up care for people who have finished treatment for breast, colorectal, lung, or prostate cancer. Researchers worked with 20 rural clinics to identify gaps in care …